Condition: Oral Cancer · Lymph Node Metastasis · Sponsor: Huashan Hospital
To evaluate the clinical outcomes of 2-year lymph node metastasis rate, disease-free survival, overall survival, and health-related quality of life in the patients with cT1N0M0 oral squamous cell carcinoma, who receive primary lesion resection combined with elective neck dissection or primary lesion resection only.
This description comes directly from the study's public registry record.
Lai-ping Zhong, MD, PhD · +862152888915 · zhonglp@hotmail.com
Liang Gu, MD · +862152889999 · guliang@hotmail.com
Always discuss trial participation with your own doctor first.
| Huashan Hospital, Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06623266